Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment

Brain

Volumn 139, Issue 11, 2016, Pages 2957-2969

  Skrobot, Olivia A ^a   Attems, Johannes ^b   Esiri, Margaret ^c   Hortobágyi, Tibor ^d,e   Ironside, James W ^f   Kalaria, Rajesh N ^b   King, Andrew ^g   Lammie, George A ^h   Mann, David ⁱ   Neal, James ^h   Ben Shlomo, Yoav ^a   Kehoe, Patrick G ^a   Love, Seth ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF DEBRECEN   (Hungary)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g KING S COLLEGE HOSPITAL   (United Kingdom)

^h CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

ⁱ UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

cerebrovascular disease; neuropathology; vascular cognitive impairment; vascular dementia

Indexed keywords

HEMOSIDERIN; MYELIN; APOLIPOPROTEIN E4;

ADULT; AGED; ARTERIOLOSCLEROSIS; ARTICLE; BLOOD VESSEL WALL; BRAIN BLOOD VESSEL; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN TISSUE; BRAIN VENTRICLE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CONSENSUS DEVELOPMENT; DELPHI STUDY; EMPIRICAL RESEARCH; FEMALE; HUMAN; HUMAN TISSUE; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PERIVASCULAR SPACE; PRIORITY JOURNAL; VALIDATION STUDY; VASCULAR AMYLOIDOSIS; VERY ELDERLY; BRAIN; CEREBROVASCULAR DISORDERS; COGNITIVE DYSFUNCTION; COMPLICATION; DIAGNOSTIC IMAGING; GENETICS; MIDDLE AGED; PATHOLOGY; PROBABILITY; PROCEDURES; REPRODUCIBILITY; STANDARDS; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; BRAIN; CEREBROVASCULAR DISORDERS; COGNITIVE DYSFUNCTION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEUROPATHOLOGY; PROBABILITY; REPRODUCIBILITY OF RESULTS;

EID: 84994522987     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aww214     Document Type: Article

References (68)

1. NACC Neuropathology (NP) Diagnosis Coding Guidebook. Version 9. 1 (2008). ADC Clinical Task Force and the National Alzheimer's Coordinating Center, University of Washington. Agosta F, Pievani M, Sala S, Geroldi C, Galluzzi S, Frisoni GB, et al. White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology 2011; 258: 853-63.
2. Alafuzoff I, Gelpi E, Al-Sarraj S, Arzberger T, Attems J, Bodi I, et al. The need to unify neuropathological assessments of vascular alterations in the ageing brain: multicentre survey by the BrainNet Europe consortium. Exp Gerontol 2012; 47: 825-33.
3. Arvanitakis Z, Leurgans SE, Barnes LL, Bennett DA, Schneider JA. Microinfarct pathology, dementia, and cognitive systems. Stroke 2011; 42: 722-7.
4. Ashby EL, Miners JS, Kehoe PG, Love S. Effects of hypertension and anti-hypertensive treatment on amyloid-b (Ab) plaque load and Absynthesizing and Ab-degrading enzymes in frontal cortex. J Alzheimers Dis 2016; 50: 1191-203.
5. Barker R, Ashby EL, Wellington D, Barrow VM, Palmer JC, Kehoe PG, et al. Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia. Brain 2014; 137: 1524-32.
6. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-59.
7. Brayne C, Richardson K, Matthews FE, Fleming J, Hunter S, Xuereb JH, et al. Neuropathological correlates of dementia in over-80-yearold brain donors from the population-based Cambridge city over-75s cohort (CC75C) study. J Alzheimers Dis 2009; 18: 645-58.
8. Brundel M, de Bresser J, van Dillen JJ, Kappelle LJ, Biessels GJ. Cerebral microinfarcts: A systematic review of neuropathological studies. J Cereb Blood Flow Metab 2012; 32: 425-36.
9. Chalmers K, Wilcock GK, Love S. APOE e4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of Ab protein. Neuropathol Appl Neurobiol 2003; 29: 231-8.
10. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992; 42: 473-80.
11. Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 2005; 6: 889-98.
12. Deramecourt V, Slade JY, Oakley AE, Perry RH, Ince PG, Maurage CA, et al. Staging and natural history of cerebrovascular pathology in dementia. Neurology 2012; 78: 1043-50.
13. Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 1999; 354: 919-20.
14. Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 1997; 63: 749-53.
15. Feinstein AR, Cicchetti DV. High agreement but low kappa: I. The problems of two paradoxes. J Clin Epidemiol 1990; 43: 543-9.
16. Fernando MS, Ince PG, Function MRCC, Ageing Neuropathology Study G. Vascular pathologies and cognition in a populationbased cohort of elderly people. J Neurol Sci 2004; 226: 13-7.
17. Ferrer I. Cognitive impairment of vascular origin: neuropathology of cognitive impairment of vascular origin. J Neurol Sci 2010; 299: 139-49.
18. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: A Delphi consensus study. Lancet 2005; 366: 2112-7.
19. Gold G, Kovari E, Herrmann FR, Canuto A, Hof PR, Michel JP, et al. Cognitive consequences of thalamic, basal ganglia, and deep white matter lacunes in brain aging and dementia. Stroke 2005; 36: 1184-8.
20. Gold G, Giannakopoulos P, Herrmann FR, Bouras C, Kovari E. Identification of Alzheimer and vascular lesion thresholds for mixed dementia. Brain 2007; 130: 2830-36.
21. Greenberg SM, Gurol ME, Rosand J, Smith EE. Amyloid angiopathyrelated vascular cognitive impairment. Stroke 2004; 35: 2616-9.
22. Grinberg LT, Heinsen H. Toward a pathological definition of vascular dementia. J Neurol Sci 2010; 299: 136-8.
23. Grinberg LT, Thal DR. Vascular pathology in the aged human brain. Acta Neuropathol 2010; 119: 277-90.
24. Gwet KL. Computing inter-rater reliability and its variance in the presence of high agreement. Br J Math Stat Psychol 2008; 61: 29-48.
25. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke; a journal of cerebral circulation 2006; 37: 2220-41.
26. Halliday G, Ng T, Rodriguez M, et al. Consensus neuropathological diagnosis of common dementia syndromes: Testing and standardising the use of multiple diagnostic criteria. Acta Neuropathol. 2002; 104: 72-8.
27. Ighodaro ET, Abner EL, Fardo DW, Lin AL, Katsumata Y, Schmitt FA, et al. Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals. J Cereb Blood Flow Metab 2016, doi:10. 1177/0271678X15621574.
28. Ihara M, Okamoto Y, Takahashi R. Suitability of the Montreal cognitive assessment versus the mini-mental state examination in detecting vascular cognitive impairment. J Stroke Cerebrovasc Dis 2013; 22: 737-41.
29. Jellinger KA. Morphologic diagnosis of "vascular dementia"- A critical update. J Neurol Sci 2008; 270: 1-12.
30. Jellinger KA. Pathology and pathogenesis of vascular cognitive impairment- A critical update. Front Aging Neurosci 2013; 5: 17.
31. Jellinger KA, Attems J. Prevalence of dementia disorders in the oldestold: An autopsy study. Acta Neuropathol 2010; 119: 421-33.
32. Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 2004; 226: 75-80.
33. Keage HA, Carare RO, Friedland RP, Ince PG, Love S, Nicoll JA, et al. Population studies of sporadic cerebral amyloid angiopathy and dementia: A systematic review. BMC Neurol 2009; 9: 3.
34. Kirvell SL, Elliott MS, Kalaria RN, Hortobagyi T, Ballard CG, Francis PT. Vesicular glutamate transporter and cognition in stroke: A casecontrol autopsy study. Neurology 2010; 75: 1803-9.
35. Kovari E, Gold G, Herrmann FR, Canuto A, Hof PR, Michel JP, et al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 2004; 35: 410-4.
36. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
37. Leys D, Pruvo JP, Parent M, Vermersch P, Soetaert G, Steinling M, et al. Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder J Neurol Neurosurg Psychiatry 1991; 54: 46-50.
38. Linstone MTaH. The Delphi method: Techniques and applications. Reading, MA: Addison-Wesley Pub. Co., Advanced Book Program; 1975.
39. Love S. Neuropathological investigation of dementia: A guide for neurologists. J Neurol Neurosurg Psychiatry 2005; 76 (Suppl 5): v8-14.
40. Love S, Chalmers K, Ince P, Esiri M, Attems J, Jellinger K, et al. Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. Am J Neurodegener Dis 2014; 3: 19-32.
41. Love S, Miners JS. White matter hypoperfusion and damage in dementia: post-mortem assessment. Brain Pathol 2015; 25: 99-107.
42. Love S, Miners JS. Cerebrovascular disease in ageing and Alzheimer's disease. Acta Neuropathol 2016; 645-58.
43. McAleese KE, Firbank M, Dey M, Colloby SJ, Walker L, Johnson M, et al. Cortical tau load is associated with white matter hyperintensities. Acta Neuropathol Commun 2015; 3: 60.
44. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 2005; 65: 1863-72.
45. Miners JS, Palmer JC, Love S. Pathophysiology of hypoperfusion of the precuneus in early Alzheimer's disease. Brain Pathol 2016; 26: 533-41.
46. Miners S, Moulding H, de Silva R, Love S. Reduced vascular endothelial growth factor and capillary density in the occipital cortex in dementia with Lewy bodies. Brain Pathol 2014; 24: 334-43.
47. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-86.
48. Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: A practical approach. Acta Neuropathol 2012; 123: 1-11.
49. Neuropathology Group. Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001; 357: 169-75.
50. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, et al. Vascular cognitive impairment. Lancet Neurol 2003; 2: 89-98.
51. Pantoni L, Sarti C, Alafuzoff I, Jellinger K, Munoz DG, Ogata J, et al. Postmortem examination of vascular lesions in cognitive impairment: A survey among neuropathological services. Stroke 2006; 37: 1005-9.
52. Pendlebury ST, Cuthbertson FC, Welch SJ, Mehta Z, Rothwell PM. Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: A population-based study. Stroke 2010; 41: 1290-3.
53. Pendlebury ST, Mariz J, Bull L, Mehta Z, Rothwell PM. MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke. Stroke 2012; 43: 464-9.
54. Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ. Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy study. Neurology 2002; 58: 1629-34.
55. Richardson K, Stephan BC, Ince PG, Brayne C, Matthews FE, Esiri MM. The neuropathology of vascular disease in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Curr Alzheimer Res 2012; 9: 687-96.
56. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-60.
57. Schneider JA, Aggarwal NT, Barnes L, Boyle P, Bennett DA. The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis 2009; 18: 691-701.
58. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 2004; 62: 1148-55.
59. Sharp SI, Francis PT, Elliott MS, Kalaria RN, Bajic N, Hortobagyi T, et al. Choline acetyltransferase activity in vascular dementia and stroke. Dement Geriatr Cogn Disord 2009; 28: 233-8.
60. Smallwood A, Oulhaj A, Joachim C, Christie S, Sloan C, Smith AD, et al. Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: A pathological study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort. Neuropathol Appl Neurobiol 2012; 38: 337-43.
61. Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD, et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 2007; 62: 406-13.
62. Strozyk D, Dickson DW, Lipton RB, Katz M, Derby CA, Lee S, et al. Contribution of vascular pathology to the clinical expression of dementia. Neurobiol Aging 2010; 31: 1710-20.
63. Thal DR, Grinberg LT, Attems J. Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain. Exp Gerontol 2012; 47: 816-24.
64. Thomas T, Miners S, Love S. Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer's disease and vascular dementia. Brain 2015; 138: 1059-69.
65. Tosto G, Zimmerman ME, Hamilton JL, Carmichael OT, Brickman AM, Alzheimer's Disease Neuroimaging I. The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment. Alzheimers Dement 2015; 11: 1510-9.
66. Troncoso JC, Zonderman AB, Resnick SM, Crain B, Pletnikova O, O'Brien RJ. Effect of infarcts on dementia in the Baltimore longitudinal study of aging. Ann Neurol 2008; 64: 168-76.
67. Vinters HV, Ellis WG, Zarow C, Zaias BW, Jagust WJ, Mack WJ, Chui HC. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 2000; 59: 931-45.
68. White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci 2002; 977: 9-23.